Naked DNA for liver gene transfer.
The majority of acquired and inherited genetic disorders, including most inborn errors of metabolism, are manifested in the liver. Therefore, it is hardly any surprise to see a large number of Medline reports describing gene therapy efforts in preclinical settings directed toward this organ (Inoue et al., 2004; Oka and Chen, 2004). Of late, non-viral vectors have garnered a lot of attention from the biomedical research community engaged in liver gene therapy (Gupta et al., 2004). However, the first initiative toward gene transfer to the liver using a non-viral approach was taken by Hickman et al. (1994), who applied the technique of naked DNA injection pioneered by Wolff (1990) for skeletal muscle. Direct injection of naked DNA resulted in low, variable and localized gene expression in the rat liver. Consequently, several developments reported in the literature since then aimed to improve hepatic gene expression by employing both surgical and nonsurgical methods. These developments include the exploitation of the unique vasculature of liver as well as the use of electric and mechanical force as an adjunct to the systemic administration of the naked plasmid gene. This chapter focuses on these developments reported from various laboratories, including ours. In addition, the underlying mechanism responsible for the dramatic increase in gene expression using these latest approaches for non-viral gene transfer to the liver is also discussed.
Liu
Feng
F
Center for Pharmacogenetics, School of Pharmacy University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Tyagi
Pradeep
P
D000818:Animals; D019470:Biolistics; D004274:DNA, Recombinant / Q000008:administration & dosage* / Q000235:genetics*; D018274:Electroporation; D018014:Gene Transfer Techniques; D006801:Humans; D007267:Injections; D008099:Liver / Q000378:metabolism*; D008102:Liver Circulation; D051379:Mice
D004274:DNA, Recombinant